The illness often brings flu-like symptoms and can escalate to severe bleeding, organ failure, and even death without proper medical care ... which were the dengue vector Aedes albopictus.

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

This trend is driven by misinterpretation of culturally influenced expressions of symptoms and limited training on how BD-I presents in Black patients. Delays in seeking care – often shaped by ...

Forbes contributors publish independent expert analyses and insights. Zak Doffman writes about security, surveillance and privacy.